Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL29965113

Nc1nc(F)c(-c2ccc(C3CCNCC3)cc2)cc1-c1cc2c(cc1F)C(=O)NCC2.O=C(O)C(F)(F)F

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.38
P2RY14 Q15391 9/20 0.38
TMEM97 Q5BJF2 5/20 0.38
DRD5 P21918 4/20 0.38
ADRB3 P13945 4/20 0.38
SIGMAR1 Q99720 4/20 0.38
ADRA2B P18089 3/20 0.38
DRD1 P21728 3/20 0.38
ADRA1B P35368 3/20 0.38
HTR1A P08908 2/20 0.38
SLC6A2 P23975 2/20 0.38
AGTR1 P30556 2/20 0.38
DRD3 P35462 2/20 0.38
SLC6A3 Q01959 2/20 0.38
PDE2A O00408 1/20 0.38
PDE5A O76074 1/20 0.38
EGFR P00533 1/20 0.38
INSR P06213 1/20 0.38
ADRA2A P08913 1/20 0.38
ADRA2C P18825 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29964754 0.93 MAPK1 (0.42) MAPK1P2RY14TMEM97DRD5ADRB3
Trifluoroacetic Acid SCHEMBL29964747 0.85 CCNT1 (0.43) P2RY14PARP1
Trifluoroacetic Acid SCHEMBL29964703 0.85 MAPKAPK2 (0.34) MAPK1PARP1CYP2C9GSK3B
Trifluoroacetic Acid SCHEMBL31079404 0.83 PARP10 (0.35) MAPK1PARP1GSK3B
SCHEMBL31079093 0.83 MAPK1 (0.38) MAPK1TNKSTNKS2PARP1
SCHEMBL29964049 0.82 MAPK1 (0.55) MAPK1TNKSTNKS2GSK3B
SCHEMBL29964643 0.81 P2RY14 (0.42) P2RY14GPR119
SCHEMBL29965086 0.81 PRKCZ (0.41) MAPK1PARP1
SCHEMBL31079182 0.81 MAPK1 (0.39) MAPK1TNKSTNKS2PARP1GSK3B
SCHEMBL29964525 0.81 MAPK1 (0.39) MAPK1DRD3TNKSTNKS2PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2024-10-17 US disclosed
WO-2022226668-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2022-11-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) CMPK1, WNK1, AAK1 MAPK1 141/4885P2RY14 1350/4885TMEM97 2179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.